Note: Ingredients listed on restricted chemical lists
EC/CAS
9004-65-3
Name of the chemical
methylhydroxypropylcellulose
Concentration
*
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
*
General Information
Revision date
2018-07-24
Product name
Nabumetone Tablets, USP 500 mg & 750 mg Nabumetone
Product Synonyms
Nabumetone Tablets, USP 500 mg & 750 mg
Chemical name
4-(6-methoxynaphthalen-2-yl)butan-2-one
1.2.1 Relevant identified uses
Nonsteroidal anti-inflammatory drug
Manufacturer Name
ScieGen Pharmaceuticals, Inc
Icons in SDS
Company Information
company name
ScieGen Pharmaceuticals, Inc
Section 2
SECTION 2: Hazards identification
Fire and Explosion Health Expected to be non-combustible Nabumetone tablets are contraindicated in patients with known hypersensitivity to Nabumetone or product excipients. Nabumetone tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking Aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients. Nabumetone tablets are contraindicated for the treatment of perioperative pain in the setting of coronary artery bypass graft (CABG) surgery.
Precautionary statements
Refer to HAZARDS IDENTIFICATION section.